Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)
Singapore flag Singapore · Delayed Price · Currency is SGD · Price in USD
2.150
+0.030 (1.42%)
Feb 21, 2025, 4:23 PM SGT

Tianjin Pharmaceutical Da Ren Tang Group Corporation Company Description

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China.

It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals.

In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services.

The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers.

The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Country Singapore
Founded 1981
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 4,619

Contact Details

No contact details available.

Stock Details

Ticker Symbol T14
Exchange Singapore Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100000924